海量图书期刊资源,随时随地畅享阅读乐趣
Reply from Authors re: Nicolas Mottet. Intermittent Androgen Deprivation in Prostate Cancer: Is Everything So Clear? Eur Urol 2013;63:121–2: Intermittent Androgen Deprivation in Advanced Prostate Cancer: An Optional Treatment RegimenArto J. Salonen; Kimmo Taari; Teuvo L.J. Tammela · 2013
Intermittent androgen deprivation in advanced prostate cancerT. M. de Reijke · 1997
Intermittent Androgen Deprivation Therapy for Prostate CancerRashid, M. H. · The Oncologist · 2004
Intermittent Versus Continuous Androgen Deprivation in Prostate CancerBlack, Peter · Urology · 2013
Intermittent versus Continuous Androgen Deprivation in Prostate CancerAndriole, G.L. · Yearbook of Urology · 2013
Intermittent Androgen Deprivation Therapy in Advanced Prostate CancerAlva, Ajjai; Hussain, Maha · Current Treatment Options in Oncology · 2014
Re: Intermittent Versus Continuous Androgen Deprivation in Prostate CancerSciarra, Alessandro · European Urology · 2013
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancerDaniel J. Zabransky; Heath A. Smith; Christopher J. Thoburn; Marianna Zahurak; Daniel Keizman; Michael Carducci; Mario A. Eisenberger; Douglas G. McNeel; Charles G. Drake; Emmanuel S. Antonarakis · 2012
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examinationDaniel Keizman; Peng Huang; Mario A. Eisenberger; Roberto Pili; Jenny J. Kim; Emmanuel S. Antonarakis; Hans Hammers; Michael A. Carducci · 2011
Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: Clinical factors associated with PSA response and disease progressionDaniel Keizman; Peng Huang; Michael A. Carducci; Mario A. Eisenberger · 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyEmmanuel S. Antonarakis; Daniel Keizman; Zhe Zhang; Bora Gurel; Tamara L. Lotan; Jessica L. Hicks; Helen L. Fedor; Michael A. Carducci; Angelo M. De Marzo; Mario A. Eisenberger · 2012
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell CarcinomaKeizman, Daniel; Ish-Shalom, Maya; Sella, Avishay; Gottfried, Maya; Maimon, Natalie; Peer, Avivit; Hammers, Hans; Eisenberger, Mario A.; Sinibaldi, Victoria; Neiman, Victoria; Rosenbaum, Eli; Sarid, David; Mermershtain, Wilmosh; Rouvinov, Keren; Berger, Raanan; Carducci, Michael A. · Clinical Genitourinary Cancer · 2016
The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen DeprivationDaniel Keizman; Peng Huang; Emmanuel S. Antonarakis; Victoria Sinibaldi; Michael A. Carducci; Samuel Denmeade; Jenny J. Kim; Janet Walczak; Mario A. Eisenberger · 2011
Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents : Combined analysis of 4 phase II trialsEmmanuel S. Antonarakis; Marianna L. Zahurak; Jianqing Lin; Daniel Keizman; Michael A. Carducci; Mario A. Eisenberger · 2012
Kidney cancer: Metabolomics for targeted therapyClyne, Melanie · Nature Reviews Urology · 2012
Infection: Scoring Fournier's gangrenePayton, Sarah · Nature Reviews Urology · 2012
Management of overactive bladderGulur, Dev M.; Drake, Marcus J. · Nature Reviews Urology · 2010
Urine biomarkers in prostate cancerPloussard, Guillaume; de la Taille, Alexandre · Nature Reviews Urology · 2010
Testicular germline stem cellsKee, Kehkooi; Reijo Pera, Renee A.; Turek, Paul J. · Nature Reviews Urology · 2010
Patented prostate cancer biomarkersMurphy, Lisa; Watson, R. William · Nature Reviews Urology · 2012
Current status of vasectomy reversalSchwarzer, J. Ullrich; Steinfatt, Heiko · Nature Reviews Urology · 2013
Stones: Reducing radiation during PCNLPayton, Sarah · Nature Reviews Urology · 2013